Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Neuropharma 2017

About conference

 10th International Conference on Neuropharmacology and Neuropharmaceuticals        

                                       Oct 23-24, 2017 Dubai ,UAE

  Theme: "Recent Innovations in Neuropharmacological Studies"

Conference Series teams with CED, a Joint Accreditation Provider, as Joint Providers of accredited continuing education activities for the healthcare team consisting of physicians, nurses and pharmacists.  As Co-providers, all activities are planned and implemented in compliance with the educational standards of Joint Accreditation formed by the accreditation standards and essentials of the ACCME, the ACPE and the ANCC.  

ConferenceSeries Ltd  invites all the participants from all over the world to attend “10th International Conference on Neuropharmacology and Neuropharmaceuticals” during October 23-24, 2017 at Dubai, UAE which includes prompt Keynote Presentations, Oral talks, Poster Presentations and Exhibitions.

Neuropharma 2017 is the learning of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more. ConferenceSeries Ltd organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With individuals from around the globe concentrated on finding out about neuropharmacology and its advances; this is your best chance to achieve the biggest collection of members from the Neuropharmacology people group. Lead presentations, disseminate data, meet with present and potential researchers, make a sprinkle with new medication advancements, and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest procedures, advancements, and the most up to date overhauls in Neuropharmacology are signs of this gathering.

Target Audience:

  • Neuropharmacology Students
  • Scientists
  • Doctors
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Toxicologist
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Pharmacologists
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Science writers
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Pharmaceutical Industrialists

Sessions and Tracks

Track 1: Neuropharmacology

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology, behavioral and molecular. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 2: Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits.

The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of psychiatric and neurodegenerative diseases. It infers that brain diseases are resulted from disruption of synaptic structure and function.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 3: Clinical Neuropharmacology

Clinical neuropharmacology covers a wide range of neurologic and a few psychiatric disorders, with an emphasis on clinical relevance. Unlike most neuropharmacology texts, it is organized according to specific clinical conditions rather than type of Neuropharmacological agent. It is the science that studies the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicology, pharmacodynamics and pharmacokinetics. It also includes drug abuse, pain and hypothalamic releasing factors. Most frequently occurring neurologic disorders are included with a heavy emphasis on movement disorders.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 4: Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioural form. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioural problems, that are associated with, including antipsychotic, anxiolytic and anticonvulsant medications, acquired brain injury and psychopharmacology drugs and their interaction with neurotransmitters also include mood stabilizers and treatments prescribed for disorders of attention.

The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. The effectiveness of the drugs can be increased by prescriber’s knowledge over emotional and interpersonal issues of the patient i.e. psychology of psychopharmacology. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 5: Neurochemical Transmission

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psych pharmaceuticals, neuropeptides, or gastro transmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuron coordination, interaction of drugs and its effect on summation and transmission process and advances in astrocyte-neuron interactions in health. Astrocyte dysfunction results into neurodegenerative diseases, stroke, epilepsy, migraine and neuro inflammatory diseases.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 6: Behavioral Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, Anxiety and Autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus acumens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 7: Chemical Neurotransmitters

Neurotransmitters are endogenous, special messenger chemicals that enable neurotransmission. They transmit signals across a chemical synapse, such as a neuromuscular junction, from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. Neurotransmitters are released from synaptic vesicles in synapses into the synaptic cleft, where they are received by receptors on the target cells. Many neurotransmitters are synthesized from simple and plentiful precursors such as amino acids, which are readily available from the diet and only require a small number of biosynthetic steps for conversion.

They can also affect mood, sleep, concentration, weight, and can cause adverse symptoms when they are out of balance. These are of two types: Inhibitory and Excitatory. Acetylcholine, Glutamine and GABA are some of these neurotransmitters.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 8: Neuro Immune Pharmacology

It deals with a branch of immunology concerned with the interactions between immunological and nervous system functions also associated autoimmune diseases.  Cortical system involves the study of mapping neural systems associated in the processing of emotion, and it focuses on the cortical components of the process of recognizing facial expressions. Encephalitis is acute inflammation of the brain resulting from a viral infection or an autoimmune disease. Transverse myelitis is a pathogenically heterogeneous inflammatory disorder in which spinal cord is affected. Huntington disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability.

Blood brain barrier is a selectively permeable membrane that separates the blood in the brain from other extracellular fluids. Meningitis, epilepsy, cerebral edema, multiple sclerosis etc. are various diseases associated with it. The children of age group 1 to 14 are more prone to cancer, out of which 18% is the case of brain tumor. In the first three decades of life, central nervous system has emerged as one of the three vulnerable leading sites for cancer mortality. Cerebral lymphoma is the most rapidly increasing brain tumor.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 9: Neuroendocrinology

It is the study of interactions between the nervous system and the endocrine system, also biological features of the cells involved and their communications. Most Important aspects of neuroendocrinology are insulin receptor and hypothalamic programming; stress, coping and interactions, neuro-endocrine-immune symphony, pituitary structure and hormone secretion. Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and become severe enough to interfere with daily tasks. Amyloid plaques are also found in the brain of Alzheimer patients. Neurocognitive effects associated with therapeutic drugs and animal cognition and behaviour - Fear and aversive learning and memory.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 10: Parkinson’s Disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. It can cause neuropsychiatric disturbances that range from mild to severe. This includes disorders of speech, cognition, mood, behaviour, and thought. Mostly it is idiopathic (having no specific known cause) type. However, a small proportion of cases are known genetic factors. Other factors have been associated with the risk of developing PD, but no causal relationships have been proven. There is no cure for Parkinson's disease, but medications, surgery, and multidisciplinary management can provide relief from the symptoms.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 11: Neuroethics

It includes the social, legal and ethical consequences of advances in neuroscience. It is the amalgamation of neuroscience with ethical thoughts. The ethics of neurocognitive includes brain interventions and imagining, neurological treatments and consciousness disorders. Neuroethics encompasses a wide range of issues, which can only be sampled here. Some have close ties to traditional biomedical ethics, in that different versions of these issues can arise in connection with organ systems other than the brain. In contrast, many neuroethical issues are at least partly novel and this accounts for some of the intellectual fascination of neuroethics. These relatively newer issues force us to think about the relation between mind and brain and its ethical implications.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 12: Future Aspects of Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapy, immunoglobulin therapy, gene therapy in neuronal disorders and neural engineering. Ultrasound systems comprise 29% of the global medical imaging systems market. X-ray systems are next, with a 24% share. Positron emission tomography has seen growth but it is the smallest segment. The X-ray market is growing well due to the introduction of digital technology.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 13: Neuro Chemical Interaction

Neurons are known as excitable cells because on its surface membrane there are an abundance of proteins known as ion-channels that allow small charged particles to pass in and out of the cell. The structure of the neuron allows chemical information to be received by its dendrites, propagated through the perikaryon (cell body) and down its axon, and eventually passing on to other neurons through its axon terminal.

Neurotransmitter/receptor interactions in the field of neuropharmacology are extremely important because many drugs that are developed today have to do with disrupting this binding process.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 14: Latest Advancement in Neuropharmacological Therapy

The great advances made in the department of pharmacology have been placed in this session. A few new ones have been introduced but the most important additions have come chiefly from chemist laboratory. Chemists have gradually discovered methods to modify that composition by the introduction of new elements, and thus render these active principles more suitable and more effective for therapeutic employment.

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

Track 15: Case Study Reports

Case studies are extremely useful records of the clinical practices of a profession. They are a record of clinical interactions which help us to frame questions for more rigorously designed clinical studies. Case studies also provide valuable teaching material, demonstrating both classical and unusual presentations which may challenge the practitioner. Analysing a case study requires you to practice applying your knowledge and your thinking skills to a real situation. To learn from a case study analysis you will be “analysing, applying knowledge, reasoning and drawing conclusions.”

Related Conferences:

3rd Neurological Disorders Conference and Brain Injury, April 18- 19, 2017 London, UK; 9th Alzheimer’s Disease Conference and Dementia, October 16-18, 2017 Rome, Italy; 16th Neuro Cognitive Disorders Conference, October 09-10, 2017 London, UK; 3rd Parkinson’s Disease Conference & Movement Disorders, September 25-26, 2017 Chicago, USA; 12th Global Neurologists Meeting, Nov 27-28, 2017 Dubai, UAE; Proteostasis & Neurodegeneration Conference April 01-04 2017, Vietnam;  Schizophrenia International Research Society Conference, April 4-8 2018 Italy, Brain Conference September 24-27, 2017 Denmark, International Conference on Auditory Cortex, September 10 - 15, 2017, Canada;  Society for Neuroscience Annual Meeting,  November 11-15 2017, Washington, DC 

Related Societies:

American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, European Federation of Neurological Societies National Institute of Neurological Disorders and Stroke, Australian Neuroscience Society, The American Clinical Neurophysiology Society

 

 

Market Analysis

Summary of Neuropharma 2017 Conference:-

Neuropharma 2017 welcomes attendees, presenters, and exhibitors from all over the world to Dubai, UAE. We are delighted to invite you all to attend and register for the “10th International Conference on Neuropharmacology (Neuropharma 2017)” which is going to be held during October 23-24, 2017 at Dubai, UAE. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuropharma 2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Neuropharma 2017 organizing committee look forward to meet you at Dubai.

For more details please visit: http://neuro.pharmaceuticalconferences.com/middleeast/     

Scope and Importance:

Neuropharmacology Conference aims to provide current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioral aspects of neuropharmacology and neuroscience.

Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behavior. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

It is necessary to focus on neuropharmacology and the use of neuropharmaceuticals to transform brain processes in the way of enhancing memory, mood, sensation, thinking and attention in people. How drugs interact with the nervous system, including the spinal cord, nerves and brain. This subject is generally studied at the graduate level.

About Venue:

 Dubai is a city and emirate in the United Arab Emirates known for luxury shopping, ultramodern architecture and a lively nightlife scene. Burj Khalifa, an 830m-tall tower, dominates the skyscraper-filled skyline. At its foot lies Dubai Fountain, with jets and lights choreographed to music. On artificial islands just offshore is Atlantis, The Palm, a resort with water and marine-animal parks. The emirate's Western-style model of business drives its economy with the main revenues now coming from tourism, aviation, real estate, and financial services. Dubai was recently named the best destination for Muslim travellers by Salam Standard. It has recently attracted world attention through many innovative large construction projects and sports events. The city has become iconic for its skyscrapers and high-rise buildings, in particular the world's tallest building, the Burj Khalifa. Dubai has been criticised for human rights violations concerning the city's largely South Asian and Filipino workforce. Dubai's property market experienced a major deterioration in 2008–09 following the financial crisis of 2007–08, but the emirate's economy has made a return to growth, with a projected 2015 budget surplus. Dubai's economy is driven by trade, financial services and tourism. The trade has a long tradition in Dubai as an important port for western producers. The Port Jebel Ali , built in 1970 , is the largest built harbor in the world. Dubai is also going to become a regional center for IT and finance through the so-called free zones like Dubai Financial Centre and Dubai Internet City . Big investment in tourism by giant projects Dubai land make tourism a growing source of income.

Dubai Internet City along with Dubai Media City as constituting TECOM (Dubai Technology, Electronic Commerce and Media Free Zone Authority) has been one of the emirate's huge successes in efforts to get a more modern, service-based economy. Within TECOM has international company EMC Corporation, Ericsson, Oracle Corporation, Microsoft and IBM established.

Dubai Financial Market (DFM) was established in March 2000 as a secondary market in derivatives and bonds , both locally and internationally. During the fourth quarter of 2006, the trade volume of about 400 billion shares worth about 95 billion US dollars

Who should attend?

  • Deans
  • Research associate
  • Research members
  • Students
  • Delegates
  • Professors
  • Lab technicians
  • Directors,
  • Neurologist and Neurosurgeons
  • Neuro-oncologists and Neuroradiologists
  • Neuroscientists and Psychiatrists
  • Head of Departments, Professors and Students from Academia in the research of Neuroscience and neurology.

Why should attend?  10th International Conference on Neuropharmacology and Neuropharmaceuticals is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

  • Meet Experts & Influencers Face to Face

  • Networking Opportunities

  • New Tools 

  • Learning In a New Space

  • New Tips & Tactics

  • Greater Focus

  • The Energy of Like-Minded Individuals

  • The Serendipity of the Random Workshop

  •  Invest in Yourself

   Conference highlights:

Major Organizations Dealing with Neuropharmacological Disorders around the World

  • American Association of Neurological Surgeons
  • British Paediatric Neurology Association
  • National Institute-Neurological
  • American Academy of Neurology
  • European Neurological Societies
  • World Federation of Neurology
  • Spanish Society of Neurology
  • Neuro-Developmental Treatment Association

Organizations Dealing with Neuropharmacological Disorders in UAE

  • Stroke Association, UAE
  • The World Federation of Neurosurgical Societies
  • British Association of Stroke Physicians (BASP) – UAE
  • Saudi Association of Neurosurgery, UAE
  • Emirates Medical Association, UAE

Organizations Dealing with Neuropharmacological Disorders in Dubai

  • Dubai Health Authority
  • The American Centre for Psychiatry and Neurology, Dubai
  • Dubai Neurology , Dubai
  • American Medical Association, Dubai
  • Armada Medical Centre, Dubai

Universities working on Neuropharmacological disorders in Worldwide

  • Stanford University
  • University of California
  • University of South Carolina Beauport
  • University of Helsinki
  • California Institute of Technology
  • Yale University
  • Harvard University 
  • University of Pennsylvania
  • University of Chicago
  • The Kavli Institute for Brain Science
  • Cornell University
  • Johns Hopkins University
  • North-western University
  • Sydney Medical School
  • Institute for Stroke and Dementia Research, Munich
  • The Ohio State University

Universities associated with Neurological disorders and Stroke research in UAE

  • Alfaisal University, Saudi Arabia
  • King Saud bin Abdulaziz University, UAE
  • Umm Al-Qura University, UAE
  • American university of Beirut, Lebanon
  • University of Sharjah, Sharjah
  • Imam Muhammad ibn Saud Islamic University
  • University of Dammam, Riyadh
  • King Khalid University, Saudi Arabia

Universities associated with Neurological disorders and Stroke research in Dubai

  • Dubai Medical College, Dubai
  • Al Zahra Medical college, Dubai
  • Jumeria University, Dubai
  • American University in the Emirates, Dubai
  • RAK Medical and Health University, Dubai

 

Top Hospitals Associated with Neurological Disorders Research in World     

  • Cleveland Clinic         
  • St Jude Children's Research Hospital
  • Johns Hopkins Medicine        
  • Mayo Clinic Scottsdale AZ     
  • University of Maryland Medical Center        
  • Massachusetts General Hospital       
  • Memorial Sloan Kettering Cancer Center     
  • New York Presbyterian / Lower Manhattan Hospital           
  • Providence Health & Services           
  • Deer's Head Hospital Center 
  • Buddhist Tzu Chi General Hospital    
  • Beth Israel Deaconess Medical Center Needham    
  • Taipei Veterans General Hospital     

Top Hospitals Associated with Neurological Disorders and Stroke Research in UAE    

  • Sheikh Khalifa Medical City, Abu dhabi
  • RAK Hospital, UAE
  • Zulekha Hospital, Sharjah
  • Neuro Spinal Hospital, Dubai
  • Canadian Specialist hospital , Dubai
  • German neuroscience cent

Top Hospitals Associated with Neurological Disorders and Stroke Research in Dubai

  • Neuro Spinal Hospital, Dubai
  • Al Zahra hospital, Dubai
  • American Center for Psychiatry & Neurology, Dubai
  • Rashid Hospital, Dubai
  • Mediclinic Hospital, Dubai
  • American Hospital, Dubai

Societies Associated with Neurological and Stroke in World

  • American Society of Neurorehabilitation, USA
  • Stroke Society Of Australasia – AUSTRALIA
  • Belgian Stroke Council - BELGIUM
  • Brazilian Stroke Network - BRAZIL
  • Canadian Stroke Consortium - CANADA
  • The Chinese Stroke Association (CSA) - CHINA
  • The Japan Stroke Society - JAPAN
  • Korean Stroke Society - KOREA, SOUT

Societies Associated with Neurological and Stroke in UAE

  • Society for Arab Neuroscientist, Saudi Arabia
  • Riyadh Neurosciences Club
  • Saudi Neurological Society, Riyadh
  • Saudi Association of Neurological Surgery
  • Pan Arab Neurosurgical Society

Societies Associated with Neurological and Stroke in Dubai

  • Emirates Neuroscience Society
  • Emirates Neurology Society
  • German Neuroscience centre

Companies Associated With Neurological Disorders and Stroke in World

  • Abbott Laboratories
  • Cordis Corporation
  • Boston Scientific Corporation
  • Siemens AG
  • Genentech, Inc.
  • Koninklijke Philips N.V.
  • Medtronic ply
  • GE Healthcare
  • Stryker Corporation
  • AstraZeneca
  • Forest Laboratories
  • Chelsea therapeutics
  • Upshers-smith laboratories

Companies Associated With Neurological Disorders and Stroke in UAE

  • Pfizer UAE      
  • Johnson & Johnson Middle East         
  • Novo Nordisk Pharma Gulf
  • Gulf Pharmaceutical Industry-Julphar (JULPHAR)     
  • Smart Health and Nutrition Ltd.
  • Hikma Pharmaceuticals PLC  
  • Valeant Pharmaceuticals MEA FZ LLC
  • Sanofi Aventis UAE     
  • Astra Zeneca UAE      
  • BioPharma
  • Gulf Inject 

Companies Associated With Neurological Disorders and Stroke in Dubai

  • AbbVie Biopharmaceuticals GmbH, Dubai
  • Merck Serono Middle East, Dubai
  • Hospira, dubai
  • AstraZeneca, Dubai
  • Al-Hayat Pharmaceuticals     
  • Amgen
  • Elis Pharmaceuticals Limited            

Top 20 neurology products in the U.S. based on revenue in 2016 (in million U.S. dollars)

 

            

This statistic displays the projected top 20 products for neurology diseases based on revenue in the United States during 2016. In that year, Abilify, an Otsuka product, is expected to generate approximately 322 million U.S. dollars in revenues, a decrease of some 1.7 billion dollars compared to 2014, caused by patent loss.

Market Growth of Neurological Research in the last and upcoming ten years:

Global neuroscience industry demand was worth USD 24.09 Billion in 2013 and is anticipated to reach above USD 30.80 billion by 2020. Rising investment in R&D resulting in the development of numerous products in the neuroinformatics coupled with adequate funding from the government are key factors that drive growth in this market. Neuro-informatics involve designing and developing efficient tools and algorithms that can augment the performance of structural and functional mapping. Global Neuroscience market is expected to grow at CAGR of 2.9% over the next seven years. Key companies include Sutter Instrument Corporation, Trifoil Imaging Inc., Newport Corporation, Femtonics Ltd., Neurotar Ltd., Scientifica Ltd, Intan Technologies, Axion Biosystems NeuralynxInc, Blackrock Microsystems LLC, mas Recording GmbH, LaVisionBiotec GmbH, PlexonInc, Mediso Medical Imaging Systems, NeuroNexus Technologies and Alpha Omega. The Global neurology market contributes to $34.5 billion which includes major countries such as US (74%), Europe (64%), japan (8.3%), and UAE (7.8%).
Country Statistics:-  The CNS disorders market may be segmented into numerous subcategories, including Alzheimer's disease (AD), epilepsy, insomnia, major depressive disorder (MDD), Parkinson's disease (PD), migraine, schizophrenia, attention-deficit hyperactivity disorder (ADHD), bipolar disorder among others. Antipsychotics were the largest CNS drug class. Patent expirations of key brands Seroquel and Zyprexa will form the main resistors to segmental growth through 2016.

  • In 2013-14 Alzheimer’s Research UAE spent approx. £8.7m on research projects. They focused projects into Alzheimer’s and dementia types such as vascular dementia frontotemporal dementia and Lewy bodies dementia.
  • The Global Acute Ischemic Stroke (AIS) market predicted an increase in the rate of stroke market growth of 3.4 % from  $2.9 billion in 2008 to $3.6 billion by 2015. Brain Research through Advancing Innovative neurotechnologies is a research effort launched by the Obama Administration to map the human brain working. In FY 2014, a $100 million fund was issued in name of the National Institutes of Health.
  • The Human Brain Project is one of the longest running projects; the project cost is estimated at 1.19 billion euros and planned to last ten years (2013-2023).
  • Parkinson Society Canada, Funding: $1,628,076, Duration: December 1, 2009 - March 31, 2014.

Market Value on Pharmaceutical Research:

The Global neurology market contributes to $34.5 billion which includes major countries such as US (74%), Europe (64%), japan (8.3%), and UAE (7.8%)

Statistical   representation:-

Funds allotted to Neurological Research:-

The Neurological Foundation is pleased to announce that funding of $1,382,529 for neurological research projects, two postgraduate scholarships, three postdoctoral fellowships, and two summer studentships has been approved in its December 2016 grant round. This brings the total research funding allocated by the Foundation in 2016 to $2,723,131. The Neurological Foundation is the primary non-government funder of neurological research in New Zealand, and also sponsors the Neurological Foundation Douglas Human Brain Bank and the Neurological Foundation Chair of Clinical Neurology research program me.Neurological Foundation Executive Director Max Ritchie says “This grant round’s recipients demonstrate the highly innovative thinking that enables New Zealand to remain at the leading edge of research into the understanding, prevention and treatment of neurological disorders.

Furthermore, this innovation provides real hope for the one in five New Zealanders across all age groups who will be diagnosed with a brain disorder in their lifetime.”

Description: NH research fund.webp (483×291)

NINDS- National Institute of Neurological Disorders and Stroke  Funding Strategy- $1.6bi

NIHR- National Institute for Health Research- $1.05 bi

GAIS- Global Acute Ischemic Stroke- $3.6 bi

BRI- Brain Research Intiative -$ 0.1 bi

AR- Alzheimer’s Research UAE -$ 0.009 bi

Federal Research

  • Grants.gov
  • NIH Grants & Funding
  • USFDA
  • NSF Funding
  • USDA NIFA Grants
  • AHRQ Funding & Grants
  • PCORI Funding
  • DOD Grants
  • DARPA (Defense Advanced Research Projects Agency)

Non-Federal Research Associations and Foundations:

  • Alex's Lemonade Stand Foundation
  • Alfred P. Sloan Foundation
  • American Cancer Society
  • American Diabetes Association
  • American Federation for Aging Research
  • American Heart Association
  • American Institute of Indian Studies
  • American Museum of Natural History
  • American Psychological Association
  • Andrew W. Mellon Foundation
  • Andy Warhol Foundation
  • Arca Foundation
  • Baxter Foundation
  • Bill and Melinda Gates Foundation

Neurological  research  funding:

  • Emerging Inkjet Printing Technologies, Applications and Global Markets: An overview of the global market for emerging inkjet printing technologies and applications, with a focus on those that have the potential to be disruptive, not just incremental improvements or refinements of existing. (e.g., consumer inkjet) technologies.

  • Synthetic Biology: Global Markets: Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells

Research Positions:-

  • Research Associate
  • Research Scientist

Clinical Development and medical Jobs:-

  • Clinical Research Physician
  • Clinical Research Associate
  • Regulatory Affairs Associate
  • Bio Statistician
  • Clinical Data Manager
  • Medical Science Liaison

Manufacturing and Quality Assurance Jobs:-

  • Process Engineer
  • Quality Control Analyst
  • Quality Assurance Specialist

Business Operations Jobs:-

  • Market research Analyst
  • Associate Product Manager
  • Product Manager
  • Strategy Director
  • Business Development Manager

Apart from the industrial personnel where most of the research work is done, other research communities include:-

  • Academicians include Student community.
  • Researchers include Post docs, Research Associates.
  • Scientists include Professors, Associate professors, and Assistant professor.
  • Industries include Presidents, CEO’s, and R&D Managers.

Statistical   representation:-

Bilbiliography:-

https://www.aan.com/PressRoom/home/PressRelease/1457 

https://www.neurotechindustry.org/members

 http://www.grandviewresearch.com/industry-analysis/neuroscience-market

https://www.aan.com/research-and-awards/clinical-research-training-fellowships/

https://www.ninds.nih.gov/Current-Research

http://finance.mapsofworld.com/company/pharmaceutical/uae-dubai

http://finance.mapsofworld.com/company/pharmaceutical/uae-dubai.html

http://pharmatips.doyouknow.in/Articles/Pharma-Companies/List-Of-Top-10-Pharma-Companies-Worldwide.aspx

http://health.usnews.com/best-hospitals/rankings/neurology-and-neurosurgery

http://www.wfns.org/pages/members/98.php

http://www.prnewswire.com/news-releases/uae-pharmaceutical-market-at-37b-by-2020-healthcare-industry-in-united-arab-emirates-forecast-to-show-significant-growth-potential-274356961.html

Past Conference Report

Neuropharmacology 2016

Neuropharmacology 2016 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Neuropharmacology 2016 Conference the best ever!

The 4th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series LLC was held during September 14-16, 2016 at Hilton San Antonio Airport, San Antonio, USA based on the theme Innovations and Complications in Neuropharmacological Studies". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

Conference Series LLC expresses its gratitude to the conference Moderator, namely Dr. Reginald Lafleur and Phenix Alcide from Harlem Cardiology, USA for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

We are grateful to our Symposium and workshop organizers. The list comprises:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Neuro Immune Pharmacology
  • Molecular Neuropharmacology
  • Psychopharmacology
  • Neurochemical Transmission
  • Behavioral Neuropharmacology
  • Neurotechnology
  • Neuroendocrinology
  • Alzheimer’s Disease and Dementia
  • Parkinson’s Disease
  • Neuroethics
  • Future Aspects of Neuropharmacology
  • Clinical Neuropharmacology
  • Chemical Neurotransmitters
  • Case Study Reports
  • Entrepreneurs Investment Meet

Conference Series LLC offers its heartfelt appreciation to organizations such as Bulgarian Society of NeurologyHuman Behavior Laboratory and our esteemed supporters KOWAFederation of all European Neuroscience Societies (FENS), MedtubeSchizophrenia International Research SocietySelectScience and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conference Series LLC also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2016Conference Series LLC is proud to announce the "10th International Conference on Neuropharmacology and Neuropharmaceuticals" to be held during October 23-24, 2017 at Dubai, UAE.

For More details visit: http://neuro.pharmaceuticalconferences.com/middleeast/


Past Reports  Proceedings  Gallery  

Supported By

Neurochemistry & Neuropharmacology: Open Access Journal of Neurological Disorders Journal of Neurology & Neurophysiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos